Table 3. CSF biomarker levels in converters and non-converters MCI patients.
| Patients with MCI | |||||
| All | Converters | Non converters | |||
| CSF biomarkers | (N = 11) | (N = 7) | (N = 4) | Statistica | P-valuea |
| Aβ 1-42, pg/mL, mean (SD) | 608.7 (276.4) | 657.7 (281.6) | 523.0 (283.9) | 1.76 | 0.18 |
| Tau, pg/mL, mean (SD) | 316.1 (124.2) | 329.6 (45.0) | 292.5 (214.9) | 1.75 | 0.19 |
| p-Tau 181 pg/mL mean (SD) | 63.1 (18.8) | 67.2 (14.3) | 56.0 (25.8) | 0.57 | 0.45 |
| p-Tau 181/Tau ratio, mean (SD) | 1.10 (0.37) | 1.16 (0.36) | 1.00 (0.43) | 0.89 | 0.34 |
| T-PKR, ODU, mean (SD) | 75.3 (21.6) | 82.2 (20.3) | 63.3 (20.6) | 2.89 | 0.09 |
| pPKR, ODU, mean (SD) | 84.9 (40.4) | 94.8 (37.6) | 67.7 (44.7) | 1.75 | 0.19 |
a
Kruskal-Wallis Test.